Skip to main content

Peer Review reports

From: Enhancing SHP-1 expression with 5-azacytidine may inhibit STAT3 activation and confer sensitivity in lestaurtinib (CEP-701)-resistant FLT3 -ITD positive acute myeloid leukemia

Original Submission
31 Dec 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Author responded Author comments
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
Author responded Author comments
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
7 Oct 2015 Editorially accepted
7 Nov 2015 Article published 10.1186/s12885-015-1695-x

You can find further information about peer review here.

Back to article page